<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

a573f716

The Indian government has taken two loans totaling $1350 M from a Chinese-controlled bank in the middle of the border standoff.

India has taken two loans worth ₹ 9,202 crores from the Asian Infrastructure Investment Bank to fight against the COVID-19 crises in May and June.

India has taken two loans worth ₹ 9,202 crores from the Asian Infrastructure Investment Bank to fight against the COVID-19 crises in May and June.On June 19, 2020, the Indian government signed an agreement with the AIIB for a $750 million loan under the COVID-19 Active Response and Expenditure Support Programme to strengthen the pandemic's adverse effect. AIIB is a multilateral development bank with a mission to improve social and economic outcomes in Asia. China is the largest shareholder of the Bank, and it is headquartered in Beijing.

Earlier, an amount of $500 million in loans was sanctioned for the COVID-19 Emergency Response and Health Systems Preparedness Project. The second amount from the Bank is under the COVID-19 Crisis Recovery Facility(CRF), which was established as part of the coordinated international response to counter the pandemic, to support AIIB members' urgent economic, financial, and public health needs. A total amount of $2.250 would be financed by the Asian Infrastructure Investment Bank(AIIB) and the Asian Development Bank(ADB). AIIB would provide $750 million, and the Asian Development Bank will provide $ 1.5 billion.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.